Building Relationships, Raising Capital, and Establishing Reimbursement Codes

Interview with Oculogica CEO Rosina Samadani

If you watch football or read the news, you already know that concussions have become an area of increasing concern for many sports associations, particularly the National Football League (NFL).

Rosina Samadani initially watched the emerging discourse around concussions play out from the sidelines of her sister’s medtech company, Oculogica. Rosina’s sister, Dr. Uzma Samadani, is a renowned neurosurgeon at the University of Minnesota At that point in time, she was in the preliminary stages of developing the EyeBOX: a cutting edge medical device designed to diagnose concussions by reading cranial nerve palsies.

Uzma periodically tapped Rosina for advice in the early days. As a serial entrepreneur with a PhD in biomedical engineering, Rosina wasn’t just a trustworthy and supportive sister, she was also a valuable consultant. Rosina eventually moved over to work on the project full time, and is now the CEO of Oculogica.

In this episode of Medsider, Rosina shares her advice for managing various stages of the regulatory journey, the importance of nurturing relationships with key stakeholders, and why entrepreneurs shouldn’t be intimidated by the complex reimbursement process.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest